Nov 12, 2025 08:00AM
Oct 20, 2025 08:18AM
Oct 20, 2025 06:56AM
Oct 18, 2025 03:00AM
Oct 14, 2025 08:01AM
Oct 14, 2025 08:00AM
Sep 18, 2025 06:39AM Mizuho Reiterates Outperform Rating on Corbus Pharmaceuticals (CRBP)
Sep 16, 2025 08:01AM
Sep 16, 2025 08:00AM
Sep 11, 2025 08:18AM
Aug 5, 2025 08:00AM
May 7, 2025 07:17AM
May 6, 2025 08:00AM
Mar 12, 2025 06:40AM Corbus Pharmaceuticals (CRBP) PT Lowered to $50 at H.C. Wainwright
Mar 11, 2025 08:00AM
Jan 2, 2025 12:51PM
Dec 3, 2024 07:00AM
Dec 3, 2024 07:00AM
Aug 6, 2024 08:00AM
May 7, 2024 08:00AM
Apr 24, 2024 04:05PM Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Apr 2, 2024 08:00AM
Mar 12, 2024 08:00AM
Jan 26, 2024 07:30AM
Jan 26, 2024 07:30AM
Jan 23, 2024 08:00AM
Jan 9, 2024 08:00AM
Dec 18, 2023 08:00AM Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU
Nov 7, 2023 08:00AM
Oct 3, 2023 08:00AM
Aug 8, 2023 08:00AM
May 9, 2023 08:00AM
Feb 13, 2023 06:56AM
Feb 13, 2023 06:55AM
Mar 2, 2022 07:02AM Akari Therapeutcis (AKTX) Appoints Rachelle Jacques as President and CEO
Mar 2, 2022 07:00AM
Nov 16, 2021 08:45AM
Nov 12, 2021 08:05AM
Aug 12, 2021 08:05AM
Aug 12, 2021 08:05AM
Jun 24, 2021 08:06AM
Jun 24, 2021 08:05AM Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
Jun 24, 2021 08:05AM
Apr 20, 2021 08:08AM
Apr 20, 2021 08:05AM
Apr 20, 2021 08:05AM
Mar 30, 2021 08:08AM
Mar 30, 2021 08:05AM
Mar 30, 2021 08:05AM Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
Dec 21, 2020 08:59AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All